What Is TMO Fair Value?
Thermo Fisher Scientific Inc. (TMO) fair value estimate using multiple valuation models, updated daily.
As of August 1, 2026, Thermo Fisher Scientific Inc. (TMO) has a composite fair value estimate of $280.22 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $574.30, suggesting the stock is overvalued by 51.2%.
Data as of August 1, 2026 (today)
Composite Fair Value
Overvalued4 of 4 models$280.22
vs. current price of $574.30(-51.2%)
How Is TMO Fair Value Calculated?
Four independent models estimate what TMO is worth. Each uses different inputs and assumptions. The composite blends them by weight.
TMO Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$341.45
-40.5%Overvalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$44.19
-92.3%Overvalued
Inputs used
TMO Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$280.95
-51.1%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$251.04
-56.3%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $574.30 is 40.5% above this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $6.83B | $6.30B |
| Year 2 | $7.48B | $6.37B |
| Year 3 | $8.20B | $6.44B |
| Year 4 | $8.99B | $6.52B |
| Year 5 | $9.86B | $6.59B |
| Year 6 | $10.81B | $6.67B |
| Year 7 | $11.85B | $6.74B |
| Year 8 | $12.99B | $6.82B |
| Year 9 | $14.24B | $6.90B |
| Year 10 | $15.62B | $6.98B |
| Terminal Value | $271.79B | $121.44B |
What Are TMO's Key Financial Metrics?
Earnings & Growth
Current Price
$574.30
EPS (TTM)
$18.61
Forward P/E
20.9
Profit Margin
15.0%
Cash & Balance Sheet
Free Cash Flow
6.2B
EBITDA
11.7B
Book Value
$139.75
Total Debt
42.5B
What Do Analysts Say About TMO?
Low
$520.00
Average
$627.62
High
$750.00
Upside
+9.3%
TMO Fair Value FAQ
What is the fair value of TMO?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), TMO's estimated fair value is $280.22. The stock is currently trading at $574.30, which makes it overvalued by our analysis.
How is TMO's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is TMO overvalued or undervalued?
Based on our analysis, TMO is overvalued. The current price of $574.30 is 51.2% above our estimated fair value of $280.22.
What do Wall Street analysts say about TMO?
26 analysts cover Thermo Fisher Scientific Inc. with a consensus rating of "Buy." The average price target is $627.62, ranging from $520.00 to $750.00. This implies 9.3% upside from the current price.